albuterol and rpl 554
albuterol has been researched along with rpl 554 in 3 studies
Research
Studies (3)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Calzetta, L; Cazzola, M; Facciolo, F; Matera, MG; Page, CP; Rogliani, P; Spina, D | 1 |
| Abbott-Banner, K; Bengtsson, T; Newman, K; Singh, D | 1 |
| Abbott-Banner, K; Bjermer, L; Newman, K | 1 |
Trials
2 trial(s) available for albuterol and rpl 554
| Article | Year |
|---|---|
The short-term bronchodilator effects of the dual phosphodiesterase 3 and 4 inhibitor RPL554 in COPD.
Topics: Administration, Inhalation; Aged; Albuterol; Bronchodilator Agents; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Female; Forced Expiratory Volume; Humans; Ipratropium; Isoquinolines; Lung; Male; Metered Dose Inhalers; Middle Aged; Pulmonary Disease, Chronic Obstructive; Pyrimidinones; Tiotropium Bromide; Treatment Outcome; United Kingdom | 2018 |
Efficacy and safety of a first-in-class inhaled PDE3/4 inhibitor (ensifentrine) vs salbutamol in asthma.
Topics: Administration, Inhalation; Adult; Aged; Albuterol; Asthma; Bronchodilator Agents; Cross-Over Studies; Double-Blind Method; Female; Forced Expiratory Volume; Humans; Isoquinolines; Male; Middle Aged; Nebulizers and Vaporizers; Phosphodiesterase 3 Inhibitors; Pyrimidinones | 2019 |
Other Studies
1 other study(ies) available for albuterol and rpl 554
| Article | Year |
|---|---|
Effect of the mixed phosphodiesterase 3/4 inhibitor RPL554 on human isolated bronchial smooth muscle tone.
Topics: Adrenergic beta-Agonists; Albuterol; Atropine; Bronchi; Drug Synergism; Electric Stimulation; Female; Glycopyrrolate; Humans; In Vitro Techniques; Isoquinolines; Male; Middle Aged; Muscarinic Antagonists; Muscle Contraction; Muscle Tonus; Muscle, Smooth; Phosphodiesterase 3 Inhibitors; Phosphodiesterase 4 Inhibitors; Pyrimidinones | 2013 |